Učitavanje...

Ex Vivo Treatment with a Novel Synthetic Aminoglycoside NB54 in Primary Fibroblasts from Rett Syndrome Patients Suppresses MECP2 Nonsense Mutations

BACKGROUND: Nonsense mutations in the X-linked methyl CpG-binding protein 2 (MECP2) comprise a significant proportion of causative MECP2 mutations in Rett syndrome (RTT). Naturally occurring aminoglycosides, such as gentamicin, have been shown to enable partial suppression of nonsense mutations rela...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Vecsler, Manuela, Ben Zeev, Bruria, Nudelman, Igor, Anikster, Yair, Simon, Amos J., Amariglio, Ninette, Rechavi, Gideon, Baasov, Timor, Gak, Eva
Format: Artigo
Jezik:Inglês
Izdano: Public Library of Science 2011
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3113846/
https://ncbi.nlm.nih.gov/pubmed/21695138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0020733
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!